Medx Health

Medx Health FCF Yield

The Free Cash Flow Yield of Medx Health (MDX.V) as of Oct 20, 2026 is -20.69 %. In the previous year, Free Cash Flow Yield was -13.92 % — a change of 48.64% (lower).

FCF Yield

-20.69 %

YoY

48.64%

Last updated:

Free Cash Flow Yield of Medx Health is 2025 -20.69 % . Free Cash Flow Yield of Medx Health was 2024 -13.92 % . It decreases by 48.64% lower compared to the previous year.

The Medx Health FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-14.51 CAD
Jan 1, 2019
-7.37 CAD
Jan 1, 2020
-16.16 CAD
Jan 1, 2021
-25.13 CAD
Jan 1, 2022
-15.53 CAD
Jan 1, 2023
-18.97 CAD
Jan 1, 2024
-13.92 CAD
Jan 1, 2025
-20.69 CAD
The Medx Health FCF Yield history
YEARFCF YieldYoY
-20.69 %+48.64%
-13.92 %-26.63%
-18.97 %+22.18%
-15.53 %-38.22%
-25.13 %+55.55%
-16.16 %+119.25%
-7.37 %-49.22%
-14.51 %+77.79%
-8.16 %+10.27%
-7.40 %+146.67%
-3.00 %-40.86%
-5.07 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medx Health Stock analysis

What does Medx Health do? MedX Health Corp develops and sells medical devices and software focused on skin health. Its core products include SIAscopy technology for scanning skin moles and lesions, integrated with the DermSecure telemedicine platform. The company manufactures hand-held devices like SIAMETRICS, SIMSYS, and MoleMate, which use light-based technology to detect skin issues up to two millimeters beneath the surface without pain or invasion. These devices are used in dermatology clinics and rehabilitation centers for early skin cancer detection and non-invasive treatment of pain and tissue damage. The company's telemedicine platform, SIAscopy on DermSecure, enables remote operation of its scanning technology through web-based services. Phototherapy devices utilizing lower-level laser and LED light energy are sold to healthcare providers for pain relief and tissue repair in rehabilitation settings. The primary customers are dermatologists, clinics specializing in skin health, and rehabilitation facilities seeking non-invasive diagnostic and treatment solutions. MedX Health Corp generates revenue through direct sales of its medical devices, telemedicine software, and phototherapy equipment. The SIAscopy technology and associated products are marketed to healthcare professionals in the dermatology and rehabilitation sectors. The company's focus on skin screening and pain-free tissue repair drives sales of its hand-held devices and telemedicine platform to medical institutions requiring advanced diagnostic tools. Medx Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medx Health stock

Free Cash Flow Yield of Medx Health is -20.69 % in 2025.

Free Cash Flow Yield of Medx Health changed from -13.92 % to -20.69 %, representing a 48.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Medx Health since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Medx Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Medx Health

All Key Metrics — Medx Health